Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Refractory ITP

3,712 views

Published on

Slide ประกอบการบรรยายเรื่อง refractory ITP โดย รศ.พลภัทร โรจน์นครินทร์ ในการประชุมกลางปี สมาคมโลหิตวิทยาแห่งประเทศไทย พฤศจิกายน 2552

  • Be the first to comment

Refractory ITP

  1. 1. PONLAPAT ROJNUCKARIN, M.D. PH.D. CHULALONGKORN UNIVERSITY How do I treat refractory ITP
  2. 2. Time to responses to initial treatments Blood. 2009;113:2386
  3. 3. Definition of Refractory ITP BJH 2008; 143, 16
  4. 4. Conditions to be excluded <ul><li>Drugs: estrogen, valproic acid, quinine/quinidine </li></ul><ul><li>Infections: HIV, HCV, ? H. pyroli </li></ul><ul><li>Hereditary thrombocytopenia: May-Hegglin anomaly, Bernard-Soulier syndrome </li></ul><ul><li>Myelodysplastic syndrome </li></ul><ul><li>Thrombotic thrombocytopenic purpura </li></ul><ul><li>Lymphoma, CLL </li></ul><ul><li>Autoimmune diseases </li></ul>BJH 2008; 143, 16
  5. 5. May-Hegglin Anomaly
  6. 6. Bernard-Soulier syndrome
  7. 7. Aim of therapy <ul><li>Weight against the toxicity of therapy </li></ul><ul><li>Start treatment: Platelet < 30 x 10 9 /L or bleeding </li></ul><ul><li>Initial aim: Platelet > 100 x 10 9 /L </li></ul><ul><li>Poorly responsive or steroid-dependent ITP </li></ul><ul><ul><li>Platelet > 30 x 10 9 /L and No bleeding </li></ul></ul><ul><ul><li>Requires prednisolone < 10 mg/d </li></ul></ul><ul><li>Refractory </li></ul><ul><ul><li>? 10-20 x 10 9 /L </li></ul></ul><ul><ul><li>No clinical bleeding (Only bruises) irrespective of platelet count </li></ul></ul>
  8. 8. Initial treatment <ul><li>Prednisolone 1 mg/kg/d </li></ul><ul><li>Dexamethasone 40 mg/d x 4 days </li></ul><ul><ul><li>Every 4 weeks x 6 cycles </li></ul></ul><ul><ul><li>Followed by prednisolone 0.5 mg/kg/d </li></ul></ul><ul><li>Dexamethasone: lower steroid cumulative dose, but it is intolerable (Dizziness, insomnia, psychosis) in some patients. </li></ul>
  9. 9. P=.016 P=.046 Praituan, JTH 2009; 7: 1036
  10. 10. Prednisolone tapering <ul><li>Depending on plt response, Hx of relapse, steroid side effects </li></ul><ul><li>60 to 30 mg/d: 5 mg/wk </li></ul><ul><li>30 to 0 mg/d : very slowly, e.g. 6 months or more </li></ul><ul><li>Too rapid tapering may result in severe thrombocytopenia refractory to treatments </li></ul>
  11. 12. Splenectomy <ul><li>Complete Response (plt > 100 x10 9 ) 1731/2623 (66%) </li></ul><ul><li>Response in 3-4 days (within 10 days) </li></ul><ul><li>15% relapse (median of 33 months FU) </li></ul><ul><li>No reliable predictor of response (controversial) </li></ul><ul><ul><li>Young </li></ul></ul><ul><ul><li>Responsive to IVIg ( N Engl J Med 1997 ;336:1494 ) </li></ul></ul>Kojouri K et al, Blood 2004
  12. 13. Splenectomy <ul><li>Laparotomy </li></ul><ul><ul><li>12.9% complication (318/2465) </li></ul></ul><ul><ul><li>1% mortality (48/4955) </li></ul></ul><ul><li>Laparoscopy </li></ul><ul><ul><li>9.6% complication (88/921) </li></ul></ul><ul><ul><li>0.2% mortality (3/1301) </li></ul></ul><ul><li>Post-splenectomy sepsis 1/1500/yr </li></ul>Kojouri K et al, Blood 2004
  13. 14. Laparoscopic Splenectomy
  14. 15. Treatment of ITP
  15. 16. Refractory ITP denied splenectomy. <ul><li>19 patients </li></ul><ul><li>On Steroid/Danazol </li></ul><ul><li>All finally can stop therapy. </li></ul><ul><li>10: normal count (FU 7.7 (1-12) yr) </li></ul><ul><li>9: platelet increased (FU 10.3 (3-15) yr) </li></ul><ul><li>Spontaneous remissions are reported ( Ann Hematol. 2007; 86: 705 ). </li></ul>McMillan
  16. 17. Pulse Dexamethasone <ul><li>10 pt refractory ITP </li></ul><ul><li>Dexamethasone 40 mg/d X 4d every 28 days for 6 cycles </li></ul><ul><li>All have some responses </li></ul><ul><li>Later reports cannot reproduce this result. </li></ul>N Engl J Med 1994 ;330:1560-4
  17. 18. Dapsone <ul><li>75-100 mg/d, inexpensive </li></ul><ul><li>Mild hemolysis: macrophage blocking </li></ul><ul><li>Response 33/66 </li></ul><ul><li>Usually relapse after stop the drug </li></ul><ul><li>SE: Hemolysis (G6PD def), Methemoglobinemia, agranulocytosis, liver toxicity </li></ul>Br J Haematol. 1997;97:336-9.
  18. 19. Colchicine <ul><li>Microtubule inhibitor in macrophage </li></ul><ul><li>1-2 mg/d </li></ul><ul><li>Effective 4/14 refractory case </li></ul><ul><li>SE: minimal, Nausea, Diarrhea </li></ul>Arch Intern Med. 1984; 144:2198
  19. 20. Danazol <ul><li>Attenuated androgen (600 mg/d, ฿ 60/d) </li></ul><ul><li>62.7% Good Response (may need 3-6 m.) </li></ul><ul><ul><li>82% Older women </li></ul></ul><ul><ul><li>18% Younger women </li></ul></ul><ul><li>71% of responses are long lasting. </li></ul><ul><li>Edema, Hirsutism, amenorrhea, liver toxicity </li></ul>Ahn YS. Acta Haematol. 1990;84: 122-9 Maloisel F. Am J Med. 2004; 116: 590-4
  20. 21. Rituximab <ul><li>Rituximab weekly X 4 (n= 79, pooled data) </li></ul><ul><li>55% OR, 28% sustained response </li></ul><ul><li>Effective even post splenectomy </li></ul><ul><li>Long duration of disease: poor response </li></ul><ul><li>CR: fewer relapses than PR </li></ul><ul><li>CR has lower B cell counts </li></ul>Br J Haematol. 2004 Apr;125(2):232-9.
  21. 22. Outcomes of Rituximab Blood. 2008;112:999
  22. 23. Immunosuppressive agents <ul><li>Cyclophosphamide 1 mg/kg/d CR 27% </li></ul><ul><li>Azathioprine 1mg/kg/d CR17% </li></ul><ul><li>but fewer side effects </li></ul><ul><li>Cyclosporin 2.5-3 mg/kg/d </li></ul><ul><li>MMF 1.5-2.0 g/d </li></ul>Ann Intern Med. 2004; 140: 112-20
  23. 24. Cyclophosphamide <ul><li>Cheap and effective </li></ul><ul><li>Long-term side effects: Sterility, MDS </li></ul><ul><li>Recommendation </li></ul><ul><li>Low dose: 50 mg/d </li></ul><ul><li>At 6 months: try tailing off </li></ul>
  24. 25. Azathioprine <ul><li>Active Metabolite: 6-MP </li></ul><ul><li>6-MP: metabolized by Xanthine Oxidase, Thiopurine methyltransferase (TPMT) </li></ul><ul><li>NOT with allopurinol </li></ul><ul><li>TPMT polymorphism: common in Thais,* may lead to prolonged & fatal pancytopenia, alopecia (early sign) </li></ul>*Br J Clin Pharm 2004; 58: 66
  25. 26. Combination chemotherapy <ul><li>10 refractory ITP </li></ul><ul><li>Cyclophosphamide, prednisolone  VCR, procarbazine, etoposide </li></ul><ul><li>6 CR but 2 relapses </li></ul><ul><li>2 PR but 1 relapse </li></ul><ul><li>2 No response </li></ul>N Engl J Med 1993;328:1226-9
  26. 27. Steroid refractory or dependence ITP Alternatives with Low side effect Pulse Dexamethasone Colchicine, Dapsone, Danazol, Rituximab, Combinations Splenectomy Second line: Cyclophosphamide, Azathioprine, MMF, CSP Third line: Combination chemotherapy, BMT, Experimental Rx
  27. 28. Control of TPO Levels NEJM 1998; 339: 746
  28. 29. Eltrombopag vs. placebo Lancet 2009; 373: 641
  29. 30. Romiplostim: Long-term response Blood 2009; 113: 2161
  30. 31. Thrombopoietic agents <ul><li>Limitations </li></ul><ul><li>Platelet counts will drop after stopping the drugs </li></ul><ul><li>? Long-term side effects: Myelofibrosis, cataracts (Eltrombopag), thrombosis, ? Leukemia </li></ul><ul><li>Cost </li></ul>
  31. 32. Patients with major bleeding <ul><li>Pulse steroid </li></ul><ul><li>Intravenous immuniglobulin </li></ul><ul><li>Vincristine </li></ul><ul><li>Platelet transfusion </li></ul>
  32. 33. Massive platelet transfusion (N=10) 3-7 Apheresis units Thromb Haemost 2008; 100: 762
  33. 34. Take home message <ul><li>There are several choices of therapy. </li></ul><ul><li>The doctors must consider toxicity, cost and patient preference. </li></ul><ul><li>Do not over-treat the patients. </li></ul>

×